analyst forecasts

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page Piper Sandler cut Upstart Holdings, Inc. (NASDAQ: UPST) price target from $35 to $27. Piper Sandler analyst...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page Piper Sandler increased Alteryx, Inc. (NYSE: AYX) price target from $30 to $32. Piper Sandler analyst Brent...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page Keefe, Bruyette & Woods increased Bank of America Corporation (NYSE: BAC) price target from $29 to $30....

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keybanc cut Skyworks Solutions Inc (NASDAQ: SWKS) price target from $130 to $120. Keybanc analyst John...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page Needham cut Tenable Holdings, Inc. (NASDAQ: TENB) price target from $55 to $45. Needham analyst Mike Cikos...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page Needham cut Shutterstock, Inc. (NYSE: SSTK) price target from $76 to $60. Needham analyst Bernie McTernan...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Raymond James cut Eagle Materials Inc. (NYSE: EXP) price target from $193 to $170. Raymond James analyst...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Barclays increased AbbVie Inc. (NYSE: ABBV) price target from $160 to $170. Barclays analyst Carter Gould...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page Barclays cut Hub Group, Inc. (NASDAQ: HUBG) price target from $80 to $75. Barclays analyst Brandon Oglenski...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Barclays cut Dow Inc. (NYSE: DOW) price target from $56 to $52. Barclays analyst Michael Leithead...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page Raymond James raised Visa Inc. (NYSE: V) price target from $284 to $287. Raymond James analyst John Davis...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page HC Wainwright & Co. cut Can-Fite BioPharma Ltd. (NYSE: CANF) price target from $34 to $18. HC...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page B of A Securities cut Alcoa Corporation (NYSE: AA) price target from $35 to $25. B of A Securities analyst...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page HC Wainwright & Co. raised Cytokinetics, Incorporated (NASDAQ: CYTK) price target from $49 to $58. HC...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. TD Cowen cut Pioneer Natural Resources Company (NYSE: PXD) price target from $280 to $256. TD Cowen...